Stealth BioTherapeutics Corp.
05/18/2022 | Press release | Distributed by Public on 05/18/2022 06:17
Selected Financial Data - Form 6-K
STEALTH BIOTHERAPEUTICS CORP
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
(unaudited)
|
Three months ending March 31, |
||||||
|
2022 |
2021 |
|||||
|
Operating expenses: |
||||||
|
Research and development |
$ |
7,776 |
$ |
6,099 |
||
|
General and administrative |
5,298 |
4,979 |
||||
|
Total operating expenses |
13,074 |
11,078 |
||||
|
Loss from operations |
(13,074 |
) |
(11,078 |
) |
||
|
Other income (expense): |
||||||
|
Gain from remeasurement of derivative liability |
5,476 |
3,688 |
||||
|
Interest income |
3 |
1 |
||||
|
Interest expense and other |
(541 |
) |
(300 |
) |
||
|
Total other income |
4,938 |
3,389 |
||||
|
Net loss attributable to ordinary shareholders |
$ |
(8,136 |
) |
$ |
(7,689 |
) |
|
Net loss per share attributable to ordinary shareholders - basic and diluted |
$ |
(0.01 |
) |
$ |
(0.01 |
) |
|
Weighted average ordinary shares used in net loss per share attributable to ordinary shareholders - basic and diluted |
715,444,473 |
652,807,323 |
STEALTH BIOTHERAPEUTICS CORP
Condensed Consolidated Balance Sheets
(in thousands)
(unaudited)
|
March 31, |
December 31, |
|||
|
2022 |
2021 |
|||
|
Assets |
||||
|
Current assets: |
||||
|
Cash and cash equivalents |
$ |
33,834 |
$ |
47,135 |
|
Prepaid expenses and other current assets |
2,566 |
2,467 |
||
|
Total current assets |
36,400 |
49,602 |
||
|
Property and equipment, net |
88 |
97 |
||
|
Deferred financing costs and other non-current assets |
427 |
527 |
||
|
Total assets |
$ |
36,915 |
$ |
50,226 |
|
Liabilities and shareholders' deficit |
||||
|
Current liabilities: |
||||
|
Accounts payable |
$ |
4,122 |
$ |
3,467 |
|
Accrued expenses and other current liabilities |
5,613 |
7,283 |
||
|
Accrued interest payable |
154 |
78 |
||
|
Total current liabilities |
9,889 |
10,828 |
||
|
Long-term portion of debt |
13,782 |
13,656 |
||
|
Development derivative liability - related party |
65,561 |
71,037 |
||
|
Total liabilities |
89,232 |
95,521 |
||
|
Total shareholders' deficit |
(52,317 |
) |
(45,295 |
) |
|
Total liabilities and shareholders' deficit |
$ |
36,915 |
$ |
50,226 |